+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Molecular Quality Controls Market by Product (Independent, Instrument Specific), Analyte Type (Single Analyte, Multianalyte), Application (Infectious Diseases), End User (IVD Manufacturers, Research Institute) - Global Forecast to 2024

  • ID: 4751843
  • Report
  • Region: Global
  • 126 Pages
  • Markets and Markets
1 of 6
The Rising Adoption of Third-Party Quality Controls is Expected to Drive the Overall Growth of the Molecular Quality Controls Market

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Microbiologics Inc.
  • Qnostics
  • Quidel
  • Roche Diagnostics
  • MORE

“The rising adoption of third-party quality controls is expected to drive the overall growth of the molecular quality controls market.”

The molecular quality controls market is expected to grow from USD 132 million in 2018 to USD 237 million by 2024, at a CAGR of 10.2% during the forecast period. The molecular quality controls market is driven primarily by the rising adoption of third-party quality controls, an increasing number of accredited clinical laboratories, and the rising demand for external quality assessment support. However, the high costs involved in the quality control process, budget constraints in hospitals and laboratories, and the unfavorable reimbursement scenario for molecular tests are expected to restrain the growth of this market during the forecast period.

“The infectious diseases segment held the largest share of the molecular controls market in 2018.”

Based on application, the molecular controls market is divided into four major segments - infectious diseases, oncology, genetic tests, and other applications. The infectious diseases segment accounted for the largest share of the molecular controls market in 2018. The large share of this segment is attributed to the development of advanced assays for different infectious diseases, a significant increase in the prevalence of infectious diseases, and the rising awareness about the effective use of MDx technologies or products to control the occurrence and spread of infectious diseases.

“Asia Pacific projected to grow at the highest CAGR during the forecast period.”

The Asia Pacific is projected to record the highest growth rate in the molecular quality controls market during the forecast period. The presence of emerging economies such as China and India and the significant demand for high-quality and accurate diagnostic tests from the large patient population in this region are the major factors supporting the growth of the Asia Pacific molecular controls market.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the molecular quality controls market.

  • By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%
  • By Designation: C-level Executives: 27%, Directors: 18%, and Others: 55%
  • By Region: North America: 50%, Europe: 20%, APAC: 20%, and RoW: 10%

Key players in the molecular quality controls market include SeraCare Life Sciences Inc. (US), ZeptoMetrix Corporation (US), Bio-Rad Laboratories Inc. (US), Microbiologics Inc. (US), and Thermo Fisher Scientific (US). The study includes an in-depth competitive analysis of these key players in the molecular quality controls market, along with their company profiles, recent developments, and key market strategies.

Research Coverage
The market study covers the molecular quality controls market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product, analyte type, application, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the revenue numbers for the overall molecular quality controls market and its subsegments. This report will help stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, and opportunities.

READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Microbiologics Inc.
  • Qnostics
  • Quidel
  • Roche Diagnostics
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Covered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Sources
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Sources
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.3.1.1 Key Industry Insights

3 Executive Summary
3.1 Introduction

4 Premium Insights
4.1 Molecular Quality Controls: Market Overview
4.2 Molecular Quality Controls Market, By Product
4.3 North America: Molecular Quality Controls Market, By End User (2018)

5 Market Overview
5.1 Introduction
5.1.1 Drivers
5.1.1.1 Increasing Number of Accredited Clinical Laboratories
5.1.1.2 Growing Adoption of Third-Party Quality Controls
5.1.1.3 Rising Demand for External Quality Assessment Support
5.1.2 Restraints
5.1.2.1 Additional Costs Involved in Quality Control and Budget Constraints in Hospitals and Laboratories
5.1.2.2 Unfavorable Reimbursement Scenario for Molecular Tests
5.1.3 Opportunities
5.1.3.1 Rising Demand for Multi-Analyte Controls
5.1.4 Challenges
5.1.4.1 Lack of Mandatory Regulations for Clinical Laboratory Accreditation in Several Emerging Countries
5.1.4.2 Complex Regulatory Frameworks

6 Molecular Quality Controls Market, By Product
6.1 Introduction
6.2 Independent Controls
6.2.1 Wide Range of Applications and Reductions in Operational Costs Have Boosted the Use of Independent Controls
6.3 Instrument-Specific Controls
6.3.1 PCR
6.3.1.1 PCR Controls Dominate the Instrument-Specific Controls Market
6.3.2 Dna Sequencing & NGS
6.3.2.1 Advancements in Sequencing Technologies Form A Positive Growth Factor for This Market
6.3.3 Other Technologies

7 Molecular Quality Controls Market, By Analyte Type
7.1 Introduction
7.2 Single-Analyte Controls
7.2.1 Significant Use of Singleplex Assays in Hospitals - A Key Market Driver
7.3 Multi-Analyte Controls
7.3.1 Increasing Preference for Multi-Analyte Controls to Fuel Market Growth

8 Molecular Quality Controls Market, By Application
8.1 Introduction
8.2 Infectious Diseases
8.2.1 Demand for Infectious Disease Testing Controls has Grown Steadily
8.3 Oncology
8.3.1 Growing Cancer Prevalence and Technological Advancements are Key Growth Drivers in This Segment
8.4 Genetic Testing
8.4.1 Advancements in Genetic Testing Drive the Market
8.5 Other Applications

9 Molecular Quality Controls Market, By End User
9.1 Introduction
9.2 Clinical Laboratories
9.2.1 Increasing Number of Accredited Clinical Laboratories to Provide Growth Opportunities in the Coming Years
9.3 Hospitals
9.3.1 Growing Patient Volume Driving the Adoption of Molecular Quality Controls in Hospital-Based Laboratories
9.4 IVD Manufacturers and Contract Research Organizations
9.4.1 Advancements in Molecular Technologies Driving the Adoption of Molecular Quality Controls Among IVD Manufacturers and Contract Research Organizations
9.5 Academic & Research Institutes
9.5.1 Increasing Demand for Ensuring the Accuracy of Diagnostic Tests to Support the Growth of This End-User Segment
9.6 Other End Users

10 Molecular Quality Controls Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 Increasing Clia Accreditation for Clinical Laboratories Driving the Market for Molecular Quality Controls in the US
10.2.2 Canada
10.2.2.1 Government Investments Supporting the Development of Advanced Diagnostic Procedures for Infectious Diseases and Cancer in Canada
10.3 Europe
10.3.1 Growing Demand for External Quality Control Support From End Users Will Provide Growth Opportunities
10.4 Asia Pacific
10.4.1 Strategic Developments By Leading Players to Drive the Market for Molecular Quality Controls in APAC
10.5 Rest of the World

11 Competitive Landscape
11.1 Market Overview
11.2 Market Ranking Analysis, 2017
11.2.1 Competitive Leadership Mapping
11.2.2 Visionary Leaders
11.2.3 Innovators
11.2.4 Dynamic Differentiators
11.2.5 Emerging Companies
11.3 Competitive Benchmarking
11.3.1 Strength of Product Portfolio (15 Players)
11.3.2 Business Strategy Excellence (15 Players)

12 Company Profiles
12.1 Seracare Life Sciences Inc.
12.2 Thermo Fisher Scientific
12.3 Bio-Rad Laboratories
12.4 Microbiologics Inc.
12.5 Zeptometrix
12.6 Roche Diagnostics
12.7 Abbott Laboratories
12.8 Quidel
12.9 Qnostics
12.10 Maine Molecular Quality Controls Inc.

13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details

List of Tables
Table 1 Molecular Quality Controls Market, By Product, 2016–2024 (USD Million)
Table 2 Independent Controls Market, By Region, 2016–2024 (USD Million)
Table 3 North America: Independent Controls Market, By Country, 2016–2024 (USD Million)
Table 4 Instrument-Specific Controls Market, By Region, 2016–2024 (USD Million)
Table 5 North America: Instrument-Specific Controls Market, By Country, 2016–2024 (USD Million)
Table 6 Instrument-Specific Controls Market, By Technology, 2016–2024 (USD Million)
Table 7 Instrument-Specific Controls Market for PCR, By Region, 2016–2024 (USD Million)
Table 8 North America: Instrument-Specific Controls Market for PCR, By Country, 2016–2024 (USD Million)
Table 9 Instrument-Specific Controls Market for Dna Sequencing & NGS, By Region, 2016–2024 (USD Million)
Table 10 North America: Instrument-Specific Controls Market for Dna Sequencing & NGS, By Country, 2016–2024 (USD Million)
Table 11 Instrument-Specific Controls Market for Other Technologies, By Region, 2016–2024 (USD Million)
Table 12 North America: Instrument-Specific Controls Market for Other Technologies, By Country, 2016–2024 (USD Million)
Table 13 Molecular Quality Controls Market, By Analyte Type, 2016–2024 (USD Million)
Table 14 Single-Analyte Controls Market, By Region, 2016–2024 (USD Million)
Table 15 North America: Single-Analyte Controls Market, By Country, 2016–2024 (USD Million)
Table 16 Multi-Analyte Controls Market, By Region, 2016–2024 (USD Million)
Table 17 North America: Multi-Analyte Controls Market, By Country, 2016–2024 (USD Million)
Table 18 Molecular Control Market, By Application, 2016–2024 (USD Million)
Table 19 Molecular Control Market for Infectious Diseases, By Region, 2016–2024 (USD Million)
Table 20 North America: Molecular Control Market for Infectious Diseases, By Country, 2016–2024 (USD Million)
Table 21 Molecular Control Market for Oncology, By Region, 2016–2024 (USD Million)
Table 22 North America: Molecular Control Market for Oncology, By Country, 2016–2024 (USD Million)
Table 23 Molecular Control Market for Genetic Testing, By Region, 2016–2024 (USD Million)
Table 24 North America: Molecular Quality Controls Market for Genetic Testing, By Country, 2016–2024 (USD Million)
Table 25 Molecular Control Market for Other Applications, By Region, 2016–2024 (USD Million)
Table 26 North America: Molecular Control Market for Other Applications, By Country, 2016–2024 (USD Million)
Table 27 Molecular Control Market, By End User, 2016–2024 (USD Million)
Table 28 Molecular Control Market for Clinical Laboratories, By Region, 2016–2024 (USD Million)
Table 29 North America: Molecular Control Market for Clinical Laboratories, By Country, 2016–2024 (USD Million)
Table 30 Molecular Control Market for Hospitals, By Region, 2016–2024 (USD Million)
Table 31 North America: Molecular Control Market for Hospitals, By Country, 2016–2024 (USD Million)
Table 32 Market for IVD Manufacturers and Contract Research Organizations, By Region, 2016–2024 (USD Million)
Table 33 North America: Molecular Control Market for IVD Manufacturers and Contract Research Organizations, By Country, 2016–2024 (USD Million)
Table 34 Molecular Control Market for Academic & Research Institutes, By Region, 2016–2024 (USD Million)
Table 35 North America: Molecular Control Market for Academic & Research Institutes, By Country, 2016–2024 (USD Million)
Table 36 Molecular Control Market for Other End Users, By Region, 2016–2024 (USD Million)
Table 37 North America: Molecular Control Market for Other End Users, By Country, 2016–2024 (USD Million)
Table 38 Molecular Control Market, By Region, 2016–2024 (USD Million)
Table 39 North America: Molecular Control Market, By Country, 2016–2024 (USD Million)
Table 40 North America: Molecular Control Market, By Product, 2016–2024 (USD Million)
Table 41 North America: Instrument-Specific Controls Market, By Technology, 2016–2024 (USD Million)
Table 42 North America: Molecular Control Market, By Analyte Type, 2016–2024 (USD Million)
Table 43 North America: Molecular Control Market, By Application, 2016–2024 (USD Million)
Table 44 North America: Molecular Control Market, By End User, 2016–2024 (USD Million)
Table 45 US: Molecular Control Market, By Product, 2016–2024 (USD Million)
Table 46 US: Instrument-Specific Controls Market, By Technology, 2016–2024 (USD Million)
Table 47 US: Molecular Control Market, By Analyte Type, 2016–2024 (USD Million)
Table 48 US: Molecular Control Market, By Application, 2016–2024 (USD Million)
Table 49 US: Molecular Control Market, By End User, 2016–2024 (USD Million)
Table 50 Canada: Molecular Control Market, By Product, 2016–2024 (USD Million)
Table 51 Canada: Instrument-Specific Controls Market, By Technology, 2016–2024 (USD Million)
Table 52 Canada: Molecular Control Market, By Analyte Type, 2016–2024 (USD Million)
Table 53 Canada: Molecular Control Market, By Application, 2016–2024 (USD Million)
Table 54 Canada: Molecular Control Market, By End User, 2016–2024 (USD Million)
Table 55 Europe: Molecular Control Market, By Product, 2016–2024 (USD Million)
Table 56 Europe: Instrument-Specific Controls Market, By Technology, 2016–2024 (USD Million)
Table 57 Europe: Molecular Control Market, By Analyte Type, 2016–2024 (USD Million)
Table 58 Europe: Molecular Control Market, By Application, 2016–2024 (USD Million)
Table 59 Europe: Molecular Control Market, By End User, 2016–2024 (USD Million)
Table 60 Asia Pacific: Market, By Product, 2016–2024 (USD Million)
Table 61 Asia Pacific: Instrument-Specific Controls Market, By Technology, 2016–2024 (USD Million)
Table 62 Asia Pacific: Market, By Analyte Type, 2016–2024 (USD Million)
Table 63 Asia Pacific: Market, By Application, 2016–2024 (USD Million)
Table 64 Asia Pacific: Market, By End User, 2016–2024 (USD Million)
Table 65 RoW: Market, By Product, 2016–2024 (USD Million)
Table 66 RoW: Instrument-Specific Controls Market, By Technology, 2016–2024 (USD Million)
Table 67 RoW: Market, By Analyte Type, 2016–2024 (USD Million)
Table 68 RoW: Market, By Application, 2016–2024 (USD Million)
Table 69 RoW: Market, By End User, 2016–2024 (USD Million)

List of Figures
Figure 1 Research Design
Figure 2 Primary Sources
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Market, By Product, 2018 (USD Million)
Figure 7 Market, By Analyte Type, 2018 vs 2024 (USD Million)
Figure 8 Market, By Application, 2018 (USD Million)
Figure 9 Market, By End User, 2018
Figure 10 Geographical Snapshot of the Market
Figure 11 Market to Register A Double-Digit Growth Rate During the Forecast Period
Figure 12 Independent Controls Segment to Register the Highest Growth During the Forecast Period (2018–2024)
Figure 13 Clinical Laboratories Accounted for the Largest Share of the North American Market in 2018
Figure 14 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 15 Number of Laboratories That Received Clia Accreditation, By Accreditation Organization (2018)
Figure 16 Geographic Snapshot: APAC Will Be the Fastest-Growing Regional Segment in the Market During the Forecast Period
Figure 17 North America: Market Snapshot
Figure 18 Asia Pacific: Market Snapshot
Figure 19 Rank of Companies in the Global Market, 2017
Figure 20 Market (Global), Competitive Leadership Mapping, 2017
Figure 21 Thermo Fisher Scientific: Company Snapshot (2017)
Figure 22 Bio-Rad Laboratories: Company Snapshot (2017)
Figure 23 Roche Diagnostics: Company Snapshot (2017)
Figure 24 Abbott Laboratories: Company Snapshot (2017)
Figure 25 Quidel: Company Snapshot (2017)

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Maine Molecular Quality Controls Inc.
  • Microbiologics Inc.
  • Qnostics
  • Quidel
  • Roche Diagnostics
  • Seracare Life Sciences Inc.
  • Thermo Fisher Scientific
  • Zeptometrix
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4751843
Adroll
adroll